LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2017 - 2026)
LivaNova (LIVN) Interest Coverage Ratio Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -6.18% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 66.99% |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn | 57.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.27% |
| Dec 31, 2025 | 67.02% |
| Sep 30, 2025 | 121.65% |
| Jun 30, 2025 | 70.62% |
| Mar 31, 2025 | 211.14% |
| Dec 31, 2024 | 141.68% |
| Sep 30, 2024 | 654.08% |
| Jun 30, 2024 | 120.40% |
| Mar 31, 2024 | 686.48% |
| Dec 31, 2023 | -639.11% |
| Sep 30, 2023 | 102.85% |
| Jun 30, 2023 | -46.84% |
| Mar 31, 2023 | -114.38% |
| Dec 31, 2022 | -73.22% |
| Sep 30, 2022 | -820.74% |
| Jun 30, 2022 | 200.52% |
| Mar 31, 2022 | 439.07% |
| Dec 31, 2021 | 124.44% |
| Sep 30, 2021 | 380.99% |
| Jun 30, 2021 | 25.05% |